Xiu‐Wu Bian

22.5k citations

278 papers · 12.8k indexed · 1 hit paper · h-index 66

Impact in

Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Oncology top 0.5%
- Cancer Cells and Metastasis

Papers in

Cancer Research 78
- MicroRNA in disease regulation 32
- Cancer, Hypoxia, and Metabolism 31
Oncology 111
- Cancer Cells and Metastasis 58
- Chemokine receptors and signaling 16

Co-authors: Yi‐Fang Ping Shi‐Cang Yu You‐Hong Cui Xiaohong Yao Cheng Qian Ji Ming Wang Senlin Xu Xia Zhang
Journals: Cancer Letters (15 papers)The Journal of Pathology (11 papers)PLoS ONE (10 papers)Laboratory Investigation (10 papers)Oncotarget (10 papers)
Partner nations: China United States Hong Kong

In The Last Decade

Xiu‐Wu Bian

268 papers receiving 12.7k citations

Hit Papers

align trajectories log scale

A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast Cancer 2023 · 113 citations

Peers

Countries citing papers authored by Xiu‐Wu Bian

Since Specialization

Citations

This map shows the geographic impact of Xiu‐Wu Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiu‐Wu Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiu‐Wu Bian more than expected).

Fields of papers citing papers by Xiu‐Wu Bian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiu‐Wu Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiu‐Wu Bian. The network helps show where Xiu‐Wu Bian may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiu‐Wu Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiu‐Wu Bian Line = papers co-authored together Xiu‐Wu Bian links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure Science Advances ·Peidi Yin, Ji-gui Yang, Yun Jiang, L. Han, Tian-Chen Xiong, Haofei Liu, Yiliang Fang, Wenchen Ruan, Jiayang Wu, Longjuan Chen, Leyong Tan, Yonglin Zuo, Xin Wu, Fangyuan Mao, Rui Huang, Xindong Liu, Xiu‐Wu Bian	2025	1
2	Gut Microbiota Modulation by Lysozyme as a Key Regulator of Vascular Inflammatory Aging Research ·Chenyang Zhang, Xin Zhao, Hang Zhang, Tongtong Wang, Zhenyu Zhang, Yilin Yin, Hui Wang, Xiao‐Min Tong, Yuzheng Xue, Yahong Zhou, Feng‐Lai Yuan, Xiu‐Wu Bian, Hong Wei, Yuan Huang, Tianhao Liu	2025	2
3	A new evaluation system for drug–microbiota interactions SHILAP Revista de lepidopterología ·Tianhao Liu, Chenyang Zhang, Hang Zhang, Jing Jin, Xue Li, Shi‐Qiang Liang, Yuzheng Xue, Feng‐Lai Yuan, Ya‐Hong Zhou, Xiu‐Wu Bian, Hong Wei	2024	5
4	Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): a single-arm, phase 2 trial EClinicalMedicine ·Yan Liang, Jing Liu, Jia Ge, Qiyun Shi, Guozhi Zhang, Andi Wan, Tao Luo, Hao Tian, Linjun Fan, Shushu Wang, Li Chen, Peng Tang, K. J. Zhu, Jun Jiang, Xiu‐Wu Bian, Yi Zhang, Xiaowei Qi	2024	4
5	Vitamin D3 attenuates SARS‐CoV‐2 nucleocapsid protein‐caused hyperinflammation by inactivating the NLRP3 inflammasome through the VDR‐BRCC3 signaling pathway in vitro and in vivo SHILAP Revista de lepidopterología ·Mingliang Chen, Ying He, Xiaofeng Hu, Xunhu Dong, Zexuan Yan, Qingning Zhao, Jingyuan Li, Dongfang Xiang, Yong Lin, Hongbin Song, Xiu‐Wu Bian	2023	10
6	Catalytic MnWO₄ Nanorods for Chemodynamic Therapy Synergized Radiotherapy of Triple Negative Breast Cancer (Adv. Funct. Mater. 47/2023) Advanced Functional Materials ·Bin Zhao, Zhili Ma, Shuaishuai Ding, Yuhua Cao, Jiangfeng Du, Lijuan Zeng, Yunping Hu, Jingrong Zhou, Xiao Zhang, Xiu‐Wu Bian, Gan Tian	2023	2
7	The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression Cancer Communications ·Ye Yuan, Lihong Wang, Xianxian Zhao, Jiao Wang, Mengsi Zhang, Qinghua Ma, Sen Wei, Zexuan Yan, Yue Cheng, Xiaohong Chen, Hongbo Zou, Jia Ge, Yan Wang, Xia Zhang, You‐Hong Cui, Tao Luo, Xiu‐Wu Bian	2022	19
8	TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer Nature Communications ·Jiahui Xu, Xiaoli Yang, Qiaodan Deng, Yang Cong, Dong Wang, Guojuan Jiang, Xiaohong Yao, Xueyan He, Jiajun Ding, Jiankun Qiang, Juchuanli Tu, Rui Zhang, Qun‐Ying Lei, Zhimin Shao, Xiu‐Wu Bian, Ronggui Hu, Lixing Zhang, Suling Liu	2021	50
9	Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma Stem Cell Research & Therapy ·Ye Yuan, Zexuan Yan, Jingya Miao, Ruili Cai, Mengsi Zhang, Yanxia Wang, Lihong Wang, Weiqi Dang, Di Wang, Dongfang Xiang, Yan Wang, Peng Zhang, You‐Hong Cui, Xiu‐Wu Bian, Qinghua Ma	2019	34
10	Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma Journal of Cellular and Molecular Medicine ·Yixing Gao, Erlong Zhang, Bao Liu, Kai Zhou, Shu He, Lan Feng, Gang Wu, Mianfu Cao, Haibo Wu, You‐Hong Cui, Xia Zhang, Xindong Liu, Yan Wang, Yuqi Gao, Xiu‐Wu Bian	2019	15
11	The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance The Journal of Immunology ·Teizo Yoshimura, Mairi H McLean, Amiran Dzutsev, Xiaohong Yao, Keqiang Chen, Jiaqiang Huang, Wanghua Gong, Jiamin Zhou, Yi Xiang, Jonathan H. Badger, Colm Ó’hUigín, Vishal Thovarai, Lino Tessarollo, Scott K. Durum, Giorgio Trinchieri, Xiu‐Wu Bian, Jiming Wang	2018	62
12	Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination The Journal of Experimental Medicine ·Xiaoguang Fang, Wenchao Zhou, Qiulian Wu, Zhi Huang, Yu Shi, Kailin Yang, Cong Chen, Qi Xie, Stephen C. Mack, Xiuxing Wang, Ángel M. Carcaboso, Andrew E. Sloan, Gaoliang Ouyang, Roger E. McLendon, Xiu‐Wu Bian, Jeremy N. Rich, Shideng Bao	2016	127
13	miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma Clinical Cancer Research ·Yu Shi, Cong Chen, Shizhu Yu, Qing Liu, Jun Rao, Huarong Zhang, Hualiang Xiao, Tiwei Fu, Hua Long, Zhicheng He, Kai Zhou, Xiaohong Yao, You‐Hong Cui, Xia Zhang, Yi‐Fang Ping, Xiu‐Wu Bian	2015	49
14	Primate-Specific miR-663 Functions as a Tumor Suppressor by Targeting PIK3CD and Predicts the Prognosis of Human Glioblastoma Clinical Cancer Research ·Yu Shi, Cong Chen, Xia Zhang, Qing Liu, Jinling Xu, Huarong Zhang, Xiaohong Yao, Tao Jiang, Zhicheng He, Yong Ren, Wei Cui, Chuan Xu, Ling Liu, You‐Hong Cui, Shizhu Yu, Yi‐Fang Ping, Xiu‐Wu Bian	2014	81
15	Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes Cancer Research ·Leina Ma, Jia Liu, Limei Liu, Guangjie Duan, Qingliang Wang, Yanmin Xu, X Y Feng, Juanjuan Shan, Junjie Shen, Zhi Yang, Ping Bie, You‐Hong Cui, Xiu‐Wu Bian, Jesús Prìeto, Matías A. Ávila, Cheng Qian	2014	74
16	CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer Clinical Cancer Research ·Yong‐Jian Deng, Na Tang, Chao Liu, Jiangyu Zhang, Shengli An, Yin-Li Peng, Lili Ma, Guang-Qiu Li, Qiang Jiang, Chun-Ting Hu, Yanan Wang, Yao-Ze Liang, Xiu‐Wu Bian, Weigang Fang, Yan-qing Ding	2014	42
17	Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells Cancer Research ·Bin Wang, Qiang Wang, Zhe Wang, Jun Jiang, Shi‐Cang Yu, Yi‐Fang Ping, Jing Yang, Senlin Xu, Xian-Zong Ye, Chuan Xu, Lang Yang, Cheng Qian, Ji Ming Wang, You‐Hong Cui, Xia Zhang, Xiu‐Wu Bian	2014	174
18	β-Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma Cancer Research ·Chuan Xu, Dan Xie, Shi‐Cang Yu, Xiao‐Jun Yang, Li-Ru He, H. J. Yang, Yi-Fang Ping, Bin Wang, Lang Yang, Sen-Lin Xu, Wei Cui, Qing-Liang Wang, Wen-Juan Fu, Qing Liu, Cheng Qian, You-Hong Cui, Jeremy N. Rich, Hsiang‐Fu Kung, Xia Zhang, Xiu‐Wu Bian	2013	79
19	Endogenous Axon Guiding Chemorepulsant Semaphorin-3F Inhibits the Growth and Metastasis of Colorectal Carcinoma Clinical Cancer Research ·Feng Wu, Qi Zhou, Jing Yang, Guangjie Duan, Juanjuan Ou, Rong Zhang, Feng Pan, Qiuping Peng, Hong Kee Tan, Yi‐Fang Ping, You‐Hong Cui, Cheng Qian, Xiao-Chu Yan, Xiu‐Wu Bian	2011	41
20	HOXB7 as a Prognostic Factor and Mediator of Colorectal Cancer Progression Clinical Cancer Research ·Wenting Liao, Dan Jiang, Jian Yuan, Yanmei Cui, Xiwen Shi, Cui-Min Chen, Xiu‐Wu Bian, Yongjian Deng, Yanqing Ding	2011	117

About Xiu‐Wu Bian

Xiu‐Wu Bian is a scholar working on Cancer Research, Oncology, Genetics, Molecular Biology and Immunology, having authored 278 papers that have together received 12.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (58 papers), Glioma Diagnosis and Treatment (33 papers), MicroRNA in disease regulation (32 papers), Cancer, Hypoxia, and Metabolism (31 papers), Immune cells in cancer (22 papers), Angiogenesis and VEGF in Cancer (16 papers), Epigenetics and DNA Methylation (16 papers) and Chemokine receptors and signaling (16 papers). The work is most often cited by research in Cancer Research (4.2k citations), Oncology (4.0k citations), Genetics (1.3k citations), Molecular Biology (7.7k citations) and Immunology (2.1k citations). Xiu‐Wu Bian has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yi‐Fang Ping, Shi‐Cang Yu, You‐Hong Cui, Xiaohong Yao, Cheng Qian, Ji Ming Wang, Senlin Xu, Xia Zhang, Hualiang Xiao and Gan Tian. Their work appears in journals such as Cancer Letters, The Journal of Pathology, PLoS ONE, Laboratory Investigation and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact